The UniSpace® Stand-Alone C Cage received FDA 510(k) clearance in April 2024. This intervertebral body fusion device is a Class II medical device designed to promote optimal bone formation and reduce subsidence.
The UniSpace® Stand-Alone C Cage has several key features that distinguish it as an advanced solution in spinal fusion technology. Its biomimetic lattice scaffolding, featuring a large graft window and two distinct porosity zones, facilitates enhanced bone formation by promoting both on growth and in growth while minimizing subsidence.
The integration of self-locking screws with an automatic locking mechanism ensures secure fixation, further supported by visual confirmation of the locking mechanism. Crafted from 3D-printed porous titanium material, the cage offers optimal osseointegration. Its adaptive sizing and variable angle screws allow for customized fit and optimized screw angulation, while an optional locking plate provides additional security against screw backout.
These features collectively enhance the efficacy and stability of spinal fusion procedures, exemplifying the UniSpace® Stand-Alone C Cage as a cutting-edge solution in orthopedic surgery.
About Innosys MT
Innosys MT has been dedicated to innovation and excellence in the medical technology industry for over 30 years. Specializing in producing high-quality orthopedic implants, Innosys offers a range of specialized products tailored for surgical centers. The company’s commitment to advancing medical technology is evident in its active involvement in the orthopedic implant sector, aiming to enhance market growth by expanding the distribution of spine implants and addressing the increasing prevalence of spine diseases. For more information about Innosys and its innovative products, attendees are encouraged to explore the company’s official website at https://mt.inno-sys.net/